NEOPLASMS, ENDOMETRIAL
Clinical trials for NEOPLASMS, ENDOMETRIAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, ENDOMETRIAL trials appear
Sign up with your email to follow new studies for NEOPLASMS, ENDOMETRIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stall endometrial cancer
Disease control Not yet recruitingThis phase 3 trial tests whether adding an experimental drug (GSK5733584) to standard immunotherapy can help keep advanced or recurrent endometrial cancer from growing. About 610 adults who have already completed initial chemotherapy with immunotherapy will receive either the new…
Matched conditions: NEOPLASMS, ENDOMETRIAL
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug combo aims to tame advanced uterine cancer
Disease control Not yet recruitingThis study tests the safety of the immunotherapy drug dostarlimab when given together with standard chemotherapy (carboplatin and paclitaxel) as a first treatment for adults in India with advanced or recurrent endometrial cancer. Participants receive the drug combination initiall…
Matched conditions: NEOPLASMS, ENDOMETRIAL
Phase: PHASE4 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC